Search Results 1111-1120 of 18675 for Relapse

  1. Hodgkin vs. non-Hodgkin lymphoma: What's the difference? - Mayo Clinic

    Some non-Hodgkin lymphomas behave like chronic conditions because they may relapse over many years. The cause of Hodgkin lymphoma and non-Hodgkin lymphoma ...

  2. Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma - Mayo Clinic

    ... relapse is allowed per local MD discretion; this should be noted on the treatment form; Absence of history of myocardial infarction =< 6 months, or ...

  3. Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate Cancer - Mayo Clinic

    ... relapse; PSA2 must be higher than PSA1, obtained at least 2 weeks after PSA1 and within 6 months or less from randomization; PSA3 must be higher than PSA2 and ...

  4. Ricardo D. Parrondo, M.D. - Doctors and Medical Staff - Mayo Clinic

    Expertise in management of relapsed/refractory plasma cell dyscrasias; Development of early and late-phase clinical trials for plasma cell dyscrasias ...

  5. Oncology (Medical) - Clinical trials

    ... Relapsed or Refractory NHL. The trial will be conducted in 2 parts: an initial Dose Escalation Phase (Part A) of CA-4948 in patients with Relapsed or ...

  6. Medical Research &amp; Education - Mayo Clinic News Network

    Root Cause of Multiple Myeloma Relapse Revealed. Dana Sparks. September 18, 2013. Cancer. Mayo Clinic Receives $8.8 Million Federal Grant for Metabolomics ...

  7. A Study to Test How Well Different Doses of BI 3706674 Are Tolerated by People With Advanced Cancer in the Stomach and Oesophagus - Mayo Clinic

    Dose escalation (Part A) only: Patients with advanced or metastatic relapsed or refractory solid tumours of any histology with KRAS wt amplification or ...

  8. Efficacy And Safety Of Nemtabrutinib (MK-1026) In Participants With Hematologic Malignancies (MK-1026-003) - Mayo Clinic

    ... relapsed or refractory following at least 1 line of prior therapy * Part 2 Cohort J: CLL/SLL participants whose disease relapsed or was refractory to prior ...

  9. CAR-T cell therapy - Care at Mayo Clinic

    Mayo Clinic researchers link CAR-T cell aging to cancer relapse · Mayo Clinic Q&A: What should I know about today's chemotherapy? Mayo Clinic Q&A ...

  10. Graft-Versus-Host Disease Clinical Trials - Mayo Clinic Research

    This study aims to determine if any of three new GVHD prophylaxis approaches improves the rate of GVHD and relapse free survival at one year after ...